Haynes BF - Search Results

1

Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection.

Yates NL, Lucas JT, Nolen TL, Vandergrift NA, Soderberg KA, Seaton KE, Denny TN, Haynes BF, Cohen MS, Tomaras GD. Yates NL, et al. Among authors: haynes bf. AIDS. 2011 Nov 13;25(17):2089-97. doi: 10.1097/QAD.0b013e32834b348e. AIDS. 2011. PMID: 21832938 Free PMC article.

2

Inhibition of HIV type 1 infection of mononuclear phagocytes by anti-CD44 antibodies.

Rivadeneira ED, Sauls DL, Yu Y, Haynes BF, Weinberg JB. Rivadeneira ED, et al. Among authors: haynes bf. AIDS Res Hum Retroviruses. 1995 May;11(5):541-6. doi: 10.1089/aid.1995.11.541. AIDS Res Hum Retroviruses. 1995. PMID: 7576909

3

HIV vaccines: where we are and where we are going.

Haynes BF. Haynes BF. Lancet. 1996 Oct 5;348(9032):933-7. doi: 10.1016/S0140-6736(96)09339-7. Lancet. 1996. PMID: 8843815 Review.

4

New frontiers of immunotherapy for HIV.

Haynes BF. Haynes BF. Lancet. 1996 Dec 7;348(9041):1531-2. doi: 10.1016/S0140-6736(05)66165-X. Lancet. 1996. PMID: 8950876 No abstract available.

5

Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research Initiative.

Bartlett JA, Wasserman SS, Hicks CB, Dodge RT, Weinhold KJ, Tacket CO, Ketter N, Wittek AE, Palker TJ, Haynes BF. Bartlett JA, et al. Among authors: haynes bf. AIDS. 1998 Jul 30;12(11):1291-300. doi: 10.1097/00002030-199811000-00010. AIDS. 1998. PMID: 9708408 Clinical Trial.

6

An inducible HIV type 1 gp41 HR-2 peptide-binding site on HIV type 1 envelope gp120.

Alam SM, Paleos CA, Liao HX, Scearce R, Robinson J, Haynes BF. Alam SM, et al. Among authors: haynes bf. AIDS Res Hum Retroviruses. 2004 Aug;20(8):836-45. doi: 10.1089/0889222041725181. AIDS Res Hum Retroviruses. 2004. PMID: 15320988

7

Antibody polyspecificity and neutralization of HIV-1: a hypothesis.

Haynes BF, Moody MA, Verkoczy L, Kelsoe G, Alam SM. Haynes BF, et al. Hum Antibodies. 2005;14(3-4):59-67. Hum Antibodies. 2005. PMID: 16720975 Free PMC article. Review.

8

Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates.

Haynes BF, Montefiori DC. Haynes BF, et al. Expert Rev Vaccines. 2006 Aug;5(4):579-95. doi: 10.1586/14760584.5.4.579. Expert Rev Vaccines. 2006. PMID: 16989638 Free article. Review.

9

Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection.

Alam SM, Scearce RM, Parks RJ, Plonk K, Plonk SG, Sutherland LL, Gorny MK, Zolla-Pazner S, Vanleeuwen S, Moody MA, Xia SM, Montefiori DC, Tomaras GD, Weinhold KJ, Karim SA, Hicks CB, Liao HX, Robinson J, Shaw GM, Haynes BF. Alam SM, et al. Among authors: haynes bf. J Virol. 2008 Jan;82(1):115-25. doi: 10.1128/JVI.00927-07. Epub 2007 Oct 17. J Virol. 2008. PMID: 17942537 Free PMC article.

10

HIV-1 hides an Achilles' heel in virion lipids.

Haynes BF, Alam SM. Haynes BF, et al. Immunity. 2008 Jan;28(1):10-2. doi: 10.1016/j.immuni.2007.12.005. Immunity. 2008. PMID: 18199412 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

782 results

Search Page

Filters